EUVIMEDEUVIMED entdecken
Crossref

IL‐17 Producing T to Foxp3 + CD4 + Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy

Jin-Sol Park, Ah-Yun Song, Ju-Young Bae, Jae Won Han, Tae Hyun Kim, Chul-Jung Kim, Sung Ki Lee iD

American Journal of Reproductive Immunology · 2024

DOI: 10.1111/aji.70020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Jin-Sol Park und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Immunoglobulins, Intravenous, Abortion, Habitual, Forkhead Transcription Factors, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, Ministry of Education, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Problem The imbalance in the Th17/Regulatory T (Treg) cell ratio is associated with recurrent pregnancy loss (RPL). This study aimed to determine a cut‐off for the Th17/Treg cell ratio to predict pregnancy outcomes in RPL and evaluate the effectiveness of intravenous immunoglobulin (IVIG) based on this cut‐off value. Method of Study This retrospective cohort study included 49 idiopathic RPL and 75 controls. The subgroups of IL‐17 + T cell to Foxp3 + T cell ratios in peripheral blood were measured using flow cytometry. The cut‐off values of Th17/Treg cell ratios were determined by the ROC curve to distinguish between RPL and controls. The IVIG treatment effectiveness in pregnancy outcome was compared between high‐ and low‐ratio groups. Pearson correlation assessed the Th17/Treg cell ratio's relationship with NK cell cytotoxicity (NKC), NK cell percentage, and Th1/Th2 cell ratio.

Results

Using the ROC curve, we identified six Th17/Treg cell ratio markers with diagnostic value, and the following two, CD3 + IL‐17 + T cell/CD3 + Foxp3 high T cell ratio (sensitivity at 97%) and CD4 + IL‐17 + T cell/CD3 + Foxp3 high T cell ratio (specificity at 93.61%), showed the highest statistical significance in diagnosing idiopathic RPL. Among the six diagnostic markers, in terms of predicting pregnancy outcomes with IVIG treatment, CD3 + IL‐17 + T cell/CD4 + Foxp3 + T cell ratio was the most valuable prognostic marker. In RPL women with high CD3 + IL‐17 + T cell/CD4 + Foxp3 + T cell ratio (≥ 1.096), the live birth rate (LBR) was improved with IVIG treatment. (IVIG treatment, 78.57% vs. no IVIG, 28.57%, p = 0.026). On the other hand, RPL women with low CD3 + IL‐17 + T cell/CD4 + Foxp3 + T cell ratio did not demonstrate the effectiveness of IVIG (LBRs with IVIG treatment, 50.00% vs. no IVIG, 84.62%, p = 0.219). In a correlation study, the CD3 + IL‐17 + T cell/CD4 + Foxp3 + T cell ratio was an independent prognostic marker, showing no correlation with NKC, NK cell percentage, and Th1/Th2 cell ratio.

Conclusion

The CD3 + IL‐17 + T/CD4 + Foxp3 + T cell ratio may serve as a valuable marker for understanding the pathogenesis of RPL, predicting pregnancy outcomes, and selecting candidates for immunotherapy. Our study demonstrates that IVIG treatment can significantly improve LBR in women with a high CD3 + IL‐17 + T/CD4 + Foxp3 + T ratio, offering a promising therapeutic approach for this challenging condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunoglobulins, IntravenousAbortion, HabitualForkhead Transcription FactorsT-Lymphocytes, RegulatoryInterleukin-17Th17 CellsHumansFemalePregnancyAdultRetrospective StudiesPrognosisBiomarkers

Stichwörter der Autor:innen

Th17 celldiagnostic markerintravenous immunoglobulinpregnancy outcomesprognostic markerrecurrent pregnancy lossregulatory T cell

Substanzen

Immunoglobulins, IntravenousForkhead Transcription FactorsFOXP3 protein, humanInterleukin-17Biomarkers

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Obstetrics and Gynecology, Konyang University Hospital, Daejeon, Republic of Korea.

ORCID-Profile: Sung Ki Lee

Förderung

  • Korea Health Industry Development Institute
  • National Research Foundation of Korea
  • Ministry of Education, Science and Technology
  • Health Industry Development Institute

Zitieren

APA

Park, J. S., Song, A. Y., Bae, J. Y., Han, J. W., Kim, T. H., Kim, C. J., & Lee, S. K. (2024). IL‐17 Producing T to Foxp3 + CD4 + Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70020

Vancouver

Park JS, Song AY, Bae JY, Han JW, Kim TH, Kim CJ, et al. IL‐17 Producing T to Foxp3 + CD4 + Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy. American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.70020

BibTeX
@article{Park2024,
  author = {Park, Jin-Sol and Song, Ah-Yun and Bae, Ju-Young and Han, Jae Won and Kim, Tae Hyun and Kim, Chul-Jung and Lee, Sung Ki},
  title = {IL‐17 Producing T to Foxp3 + CD4 + Regulatory T Cell Ratio as a Diagnostic and Prognostic Marker in Women With Recurrent Pregnancy Loss and Its Implications for Intravenous Immunoglobulin Therapy},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1111/aji.70020}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche